Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Mucous Membrane Pemphigoid and Covid-19 Treated With High-Dose Intravenous Immunoglobulins: A Case Report Publisher Pubmed



Daneshpazhooh M1 ; Soori T2 ; Isazade A1 ; Noormohammadpour P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Dermatology, Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Infectious Diseases, Autoimmune Bullous Diseases Research Center, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Dermatological Treatment Published:2020


Abstract

This is a report of a case with mucous membrane pemphigoid (MMP) with severe eye involvement and concurrent COVID-19 treated successfully using simultaneous high dose intravenous immunoglobulin (IVIg) and anti-viral treatment as hydroxychloroquine, lopinavir/ritonavir, and ribavirin. He had finished a 2-g cycle of rituximab (RTX) in late January. He was receiving mycophenolate mofetil (MMF) for one month and 30 mg prednisolone for three months until his hospitalization. Prednisolone was tapered to 15 mg when current COVID-19 was suspected, considering his recent cough, dyspnea, and fever. © 2020, © 2020 Taylor & Francis Group, LLC.
Related Docs
1. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)